Financial Statements · From SEC 10-K & 10-Q XBRL Filings
Tenet Healthcare Corporation Revenue & Financial Statements
Tenet Healthcare Corporation reported revenue of $21.3B for the fiscal year ended December 31, 2025, up 3.1% year over year, with net income of $2.4B and diluted EPS of $15.49.
- Company
- Tenet Healthcare Corporation THC · NYSE
- Latest fiscal year
- FY ended Dec 31, 2025
- Statements
- Income · Balance Sheet · Cash Flow — 5 fiscal years, 8 quarters
Income Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | 19.5B | 19.2B | 20.5B | 20.7B | 21.3B |
| Cost of revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | 2.9B | 2.3B | 2.5B | 6.0B | 3.5B |
| Pretax income | 1.9B | 1.3B | 1.6B | 5.2B | (5.0M) |
| Net income | 914.0M | 411.0M | 611.0M | 3.2B | 2.4B |
| Diluted EPS | 8.42 | 3.79 | 5.71 | 32.70 | 15.49 |
| EBITDA | 3.7B | 3.0B | 3.2B | 6.6B | 4.4B |
Quarterly
| USD | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.4B | 5.1B | 5.1B | 5.1B | 5.2B | 5.3B | 5.3B | 5.5B |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | 3.3B | 761.0M | 1.1B | 821.0M | 943.0M | 823.0M | 889.0M | 853.0M |
| Pretax income | 3.1B | 587.0M | 922.0M | 655.0M | 765.0M | 642.0M | 712.0M | 681.0M |
| Net income | 2.2B | 259.0M | 472.0M | 318.0M | 406.0M | 288.0M | 342.0M | 644.0M |
| Diluted EPS | 21.38 | 2.64 | 4.89 | 3.43 | 4.27 | 3.14 | 3.86 | 4.21 |
| EBITDA | 3.5B | 969.0M | 1.3B | 1.0B | 1.1B | 1.0B | 1.1B | 1.1B |
Balance Sheet
Fiscal year-end snapshots. Values in USD.
| USD | FY2024 | FY2024 | FY2025 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Total assets | — | 28.9B | — | 29.7B | — |
| Current assets | — | 7.7B | — | 7.8B | — |
| Cash & equivalents | — | 3.0B | — | 2.9B | — |
| Total liabilities | — | 20.4B | — | 20.7B | — |
| Current liabilities | — | 4.3B | — | 4.5B | — |
| Long-term debt | — | — | — | — | — |
| Total debt | — | — | — | — | — |
| Stockholders’ equity | — | 4.2B | — | 4.2B | — |
| Net debt | — | — | — | — | — |
Cash Flow Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | 1.6B | 1.1B | 2.4B | 2.0B | 3.5B |
| Investing cash flow | (714.0M) | (808.0M) | (969.0M) | 3.4B | (1.3B) |
| Financing cash flow | (936.0M) | (1.8B) | (1.0B) | (3.7B) | (2.4B) |
| Capital expenditure | 658.0M | 762.0M | 751.0M | 931.0M | 1.0B |
| Free cash flow | 910.0M | 321.0M | 1.6B | 1.1B | 2.5B |
| Dividends paid | — | — | — | — | — |
| Stock-based compensation | 56.0M | 56.0M | 66.0M | 67.0M | 104.0M |
Figures are parsed from SEC XBRL company facts and may be derived where issuers report year-to-date values (quarterly figures differenced; Q4 computed as FY minus Q3). Fiscal periods follow each company's fiscal calendar, not calendar years. Historical fact, not investment advice — verify with official SEC filings.
Every THC filing, connected
Financials beside price, insider trades, and 8-K events — with alerts the moment something new is filed.